• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Employers Move to Adapt to Health Law

Article

Two major provisions of the health-overhaul law take effect Wednesday, testing employers' ability to adapt to changes the measure mandates.

The law requires employers to distribute millions of dollars in insurance-company refunds to workers whose plans spent a high percentage of their premium dollars on administrative expenses instead of medical care.

Read the full story: http://tinyurl.com/czngc5r

Source: The Wall Street Journal

Related Videos
Manjool Shah, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Dr Debra Patt
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Eleanor Perfetto, PhD
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Related Content
The OCEANIC-STROKE subgroup analysis findings, in tandem with the main results presented at ISC 2026, suggest that targeting factor XIa could be a safe way to intensify antithrombotic therapy following noncardioembolic stroke, regardless of underlying etiology. | Image credit: jolygon - stock.adobe.com

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

February 6th 2026
Article

OCEANIC-STROKE shows asundexian cuts recurrent ischemic stroke risk across noncardioembolic subtypes without increasing major bleeding risk.

Read More

Managed Care Cast Square Image

The Orphan Drug Act in the Modern Drug Pricing Era

February 3rd 2026
Podcast

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Drug pricing | Image Credit: © TarikVision-stock.adobe.com

TrumpRx Launch Brings Savings—and Uncertainty

February 5th 2026
Article

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Insulin syringe | Image Credit: © ixel-Shot-stock.adobe.com

Express Scripts Avoids Fines but Agrees to Major Structural Overhaul

February 5th 2026
Article

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin.

Read More

International Stroke Conference 2026 research emphasizes that not only is the stroke treatment landscape changing, but so is stroke epidemiology research. | Image credit: samunella - stock.adobe.com

Underrecognized Stroke Risk Factors in Focus at ISC 2026

February 5th 2026
Article

Yearly dental visits were associated with fewer secondary strokes, and hyperthyroidism was flagged as a key CVST risk factor in women.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.